Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence
Tirzepatide, on the other hand, offers dual action on GLP-1 and GIP receptors, making it a preferred choice for patients seeking significant blood sugar reduction and weight loss, though it may carry a higher risk of gastrointestinal side effects
Statistics Statistical analyses were performed in SPSS version 25
In clinical trials about 2% of people or 1 in 50 who took Ozempic complained of heartburn, acid reflux, or GERD, especially those taking the drug at the lower dose
Why are you taking this medication
The needle went past 520, but it didnt blow it down, he says